Biblio

Author Title Type [ Year(Asc)]
Filters: Author is López-Corral, Lucia  [Clear All Filters]
2023
Piñana JLuis, Vázquez L, Calabuig M, López-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, et al. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Blood Cancer J. 2023;13(1):8.
Bejarano L, Sayagués JMaría, Alcoceba M, Balanzategui A, López-Corral L, Cañueto J, Santos-Briz A. Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation. Am J Dermatopathol. 2023.
Solano C, Castro-Rebollo P, Pérez-Martínez A, López-Corral L, Barba-Suñol P, Kwon M, Ortiz V, Sanz-Caballer J, Caballero ACarolina, Martínez J, et al. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study. BMJ Open. 2023;13(7):e071371.
Piñana JLuis, Heras I, Aiello TFrancesco, García-Cadenas I, Vázquez L, López-Jiménez J, Chorão P, Aroca C, Garcia-Vidal C, Arroyo I, et al. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses. 2023;15(10).
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MReyes, Bermúdez-Rodríguez MAránzazu, López-Corral L, Triguero A, Onstad L, et al. Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials. Clin Cancer Res. 2023:OF1-OF11.
2022
Piñana JLuis, Rodríguez-Belenguer P, Caballero D, Martino R, López-Corral L, Terol M-J, Vázquez L, Calabuig M, Sanz-Linares G, Marin-Jimenez F, et al. Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Ann Hematol. 2022.
Bailén R, Pascual-Cascón MJesús, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, et al. Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC. Transplant Cell Ther. 2022.
Piñana JLuis, López-Corral L, Martino R, Vázquez L, Pérez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, et al. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. J Hematol Oncol. 2022;15(1):54.
2021
Piñana JLuis, López-Corral L, Martino R, Montoro J, Vázquez L, Pérez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M-J, et al. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Am J Hematol. 2021.
2016
Labrador J, González-Rivero J, Monroy R, Lozano FS, López-Corral L, Caballero MDolores, Bastida JMaría, González-Porras JRamón. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center. Thromb Res. 2016.
2015
Alonso S, Cabrero M, Caballero JC, Dávila J, de la Calle VGonzalez, López-Godino O, López-Corral L, Pérez E, Vázquez L, Corral R, et al. Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma. Clin Case Rep. 2015;3(6):370-375.